Systematic Reviews
Copyright ©The Author(s) 2020.
World J Orthop. Jul 18, 2020; 11(7): 328-344
Published online Jul 18, 2020. doi: 10.5312/wjo.v11.i7.328
Table 1 Descriptive summaries of the identified studies investigating the effect of oxysterols on bone formation in spinal fusion models (n = 5)
Ref. (level of evidence)Species (n)Surgical model and scaffold(s) usedExperimental groups (n)Assessment method and time pointFusion rate (no. fused/total)
Johnson et al[21], 2011 (V)Rat (n = 59)L4–L5 PLF using a collagen sponge supplemented with Oxy341, Oxy49, or rhBMP-2A. DMSO only (control) (n = 9)No motion bilaterally via manual palpation at 9 wk post-operativelyA. 0% (0/9)
B. 5-μg rhBMP-2 (n = 10)B. 100% (10/10)
C. 0.2-mg Oxy34 (n = 10)C. 0% (0/10)
D. 2-mg Oxy34 (n = 10)D. 50% (5/10)
E. 20-mg Oxy34 (n = 10)E. 100% (10/10)
F. 20-mg Oxy49 (n = 10)F. 100% (10/10)
Stappenbeck et al[20], 2012 (V)Rat (n = 30)L4-L5 PLF using a collagen sponge supplemented with Oxy41, Oxy18, or Oxy212A. 2-mg Oxy4 (n = 10)Fusion rate was not reported; however, via μ-computed tomographic analysis, treatment with Oxy21 led to significantly larger de novo bone volumes compared to treatment with Oxy4, which was comparable to treatment with Oxy18
B. 2-mg Oxy18 (n = 10)
C. 2-mg Oxy21 (n = 10)
Montgomery et al[19], 2014 (V)Rat (n = 38)L4-L5 PLF using a collagen sponge supplemented with Oxy1332 or rhBMP-2A. DMSO only (control) (n = 7)No motion bilaterally via manual palpation at 8 wk post-operativelyA. 0% (0/7)
B. 5-μg rhBMP-2 (n = 8)B. 100% (8/8)
C. 0.2-mg Oxy133 (n = 8)C. 0% (0/8)
D. 2-mg Oxy133 (n = 8)D. 50% (4/8)
E. 20-mg Oxy133 (n = 7)E. 86% (6/7)
Scott et al[31], 2015 (V)Rabbit (n = 22)L4-L5 PLF using iliac crest autograft supplemented with Oxy133 or rhBMP-2A. Saline only (control) (n = 5)No motion bilaterally via manual palpation at 8 wk post-operativelyA. 0% (0/5)
B. 30-μg rhBMP-2 (n = 6)B. 83.3% (5/6)
C. 20-mg Oxy133 (n = 6)C. 83.3% (5/6)
D. 60-mg Oxy133 (n = 5)D. 80% (4/5)
Buser et al[33], 2017 (V)Rat (n = 64)L3-L5 posterolateral fusion (PLF) using a collagen sponge supplemented with Oxy133 and/or rhBMP-2A. DMSO only (control) (n = 32, 8 rats/4 segments each)No motion at the operated segment via manual palpation at 8 wk post-operativelyA. 0% (0/32)
B. 0.5-µg rhBMP-2 (n = 32, 8 rats/4 segments each)B. 69% (22/32)
C. 5-µg rhBMP-2 (n = 32, 8 rats/4 segments each)C. 100% (32/32)
D. 5-mg Oxy133 (n = 32, 8 rats/4 segments each)D. 100% (32/32)
E. 20-mg Oxy133 (n = 32, 8 rats/4 segments each)E. 100% (32/32)
F. 0.5-µg rhBMP2 + 5-mg Oxy133 (n = 32, 8 rats/4 segments each)F. 100% (32/32)
G. 0.5-µg rhBMP2 + 20-mg Oxy133 (n = 32, 8 rats/4 segments each)G. 100% (32/32)
H. 5-µg rhBMP2 + 20-mg Oxy133 (n = 32, 8 rats/4 segments each)H: 100% (32/32)